SEC Comment Letter 0000000000-22-012233 to ChromaDex Corp. (CDXC) (CIK 0001386570) (NAGE)
ChromaDex Corp. (CDXC) (CIK 0001386570)
Date: Nov. 9, 2022 · CIK: 0001386570 · Accession: 0000000000-22-012233
AI Filing Summary & Sentiment
File numbers found in text: 333-268148
Letter
United States securities and exchange commission logo November 9, 2022 Heather Van Blarcom Senior Vice President, Legal and Corporate Secretary ChromaDex Corp. 10900 Wilshire Blvd., Suite 600 Los Angeles, CA 90024 Re:ChromaDex Corp. Registration Statement on Form S-3 Filed November 3, 2022 File No. 333-268148 Dear Heather Van Blarcom: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Louis Rambo
Show Raw Text
United States securities and exchange commission logo
November 9, 2022
Heather Van Blarcom
Senior Vice President, Legal and Corporate Secretary
ChromaDex Corp.
10900 Wilshire Blvd., Suite 600
Los Angeles, CA 90024
Re:ChromaDex Corp.
Registration Statement on Form S-3
Filed November 3, 2022
File No. 333-268148
Dear Heather Van Blarcom:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Louis Rambo